Institut du Cancer de Montpellier - Val d'aurelle

Montpellier 34298

0 studies enrolling now · 3 studies all time

What they study most

Any Solid Tumor, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Colon Cancer, Colorectal Cancer, Colorectal Neoplasms, Endometrial Neoplasms, HER2 Amplification, HER2 Positive Solid Tumors, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, Medullary Thyroid Cancer

Studies at this site

• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
• ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer — Running, not enrolling